Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 1911.2
(0.19%)
INR 1911.2
(0.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.22 Billion INR | -12.4% |
| 2022 | 4.52 Billion INR | 17.24% |
| 2021 | 3.85 Billion INR | 22.89% |
| 2020 | 3.13 Billion INR | 18.71% |
| 2019 | 2.64 Billion INR | 26.65% |
| 2018 | 2.08 Billion INR | 18.35% |
| 2017 | 1.76 Billion INR | 56.75% |
| 2016 | 1.12 Billion INR | 61.01% |
| 2015 | 698.88 Million INR | 31.38% |
| 2014 | 531.96 Million INR | 59.31% |
| 2013 | 333.92 Million INR | 63.73% |
| 2012 | 203.94 Million INR | 110.66% |
| 2011 | 96.81 Million INR | 38.06% |
| 2010 | 70.12 Million INR | 56.46% |
| 2009 | 44.82 Million INR | 47.68% |
| 2008 | 30.34 Million INR | 163.94% |
| 2007 | 11.49 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.35 Billion INR | 89.83% |
| 2023 Q2 | 1.46 Billion INR | 14.86% |
| 2023 Q3 | 1.45 Billion INR | -0.41% |
| 2023 Q4 | 1.12 Billion INR | -22.52% |
| 2023 Q1 | 1.27 Billion INR | 2.41% |
| 2023 FY | 3.96 Billion INR | -12.4% |
| 2022 Q2 | 1.1 Billion INR | 5.17% |
| 2022 Q4 | 1.24 Billion INR | 10.87% |
| 2022 FY | 4.52 Billion INR | 17.24% |
| 2022 Q1 | 1.05 Billion INR | 5.15% |
| 2022 Q3 | 1.12 Billion INR | 1.37% |
| 2021 Q1 | 805.8 Million INR | 3.98% |
| 2021 Q2 | 894.5 Million INR | 11.01% |
| 2021 Q3 | 944.7 Million INR | 5.61% |
| 2021 Q4 | 1 Billion INR | 5.85% |
| 2021 FY | 3.85 Billion INR | 22.89% |
| 2020 Q1 | 626.4 Million INR | 33.09% |
| 2020 Q2 | 785.5 Million INR | 25.4% |
| 2020 Q4 | 774.98 Million INR | 3.8% |
| 2020 Q3 | 746.6 Million INR | -4.95% |
| 2020 FY | 3.13 Billion INR | 18.71% |
| 2019 Q4 | 470.66 Million INR | -20.69% |
| 2019 Q1 | 599.95 Million INR | 1.9% |
| 2019 Q2 | 637.09 Million INR | 6.19% |
| 2019 FY | 2.64 Billion INR | 26.65% |
| 2019 Q3 | 593.41 Million INR | -6.86% |
| 2018 Q1 | 475.77 Million INR | 11.83% |
| 2018 Q3 | 520.84 Million INR | 3.74% |
| 2018 Q4 | 588.79 Million INR | 13.05% |
| 2018 FY | 2.08 Billion INR | 18.35% |
| 2018 Q2 | 502.06 Million INR | 5.53% |
| 2017 Q3 | 485.91 Million INR | 0.21% |
| 2017 Q1 | 459.16 Million INR | 14.28% |
| 2017 FY | 1.76 Billion INR | 56.75% |
| 2017 Q4 | 425.43 Million INR | -12.45% |
| 2017 Q2 | 484.89 Million INR | 5.6% |
| 2016 Q1 | 211.22 Million INR | 6.64% |
| 2016 FY | 1.12 Billion INR | 61.01% |
| 2016 Q4 | 401.78 Million INR | 32.34% |
| 2016 Q3 | 303.6 Million INR | 244.23% |
| 2016 Q2 | -210.5 Million INR | -199.66% |
| 2015 Q1 | 117.63 Million INR | -22.38% |
| 2015 Q2 | 203.62 Million INR | 73.1% |
| 2015 Q4 | 198.07 Million INR | -13.6% |
| 2015 FY | 698.88 Million INR | 31.38% |
| 2015 Q3 | 229.25 Million INR | 12.59% |
| 2014 Q2 | 105.78 Million INR | 2.18% |
| 2014 Q3 | 130.76 Million INR | 23.62% |
| 2014 FY | 531.96 Million INR | 59.31% |
| 2014 Q1 | 103.53 Million INR | 41.01% |
| 2014 Q4 | 151.54 Million INR | 15.89% |
| 2013 Q2 | 104.14 Million INR | 191.89% |
| 2013 Q4 | 73.42 Million INR | -25.49% |
| 2013 FY | 333.92 Million INR | 63.73% |
| 2013 Q1 | 35.67 Million INR | -30.63% |
| 2013 Q3 | 98.54 Million INR | -5.38% |
| 2012 Q2 | 45.36 Million INR | 50502.22% |
| 2012 Q1 | -90 Thousand INR | -100.29% |
| 2012 Q4 | 51.43 Million INR | -28.04% |
| 2012 FY | 203.94 Million INR | 110.66% |
| 2012 Q3 | 71.47 Million INR | 57.56% |
| 2011 Q2 | 25.42 Million INR | 0.0% |
| 2011 FY | 96.81 Million INR | 38.06% |
| 2011 Q4 | 31.32 Million INR | 0.59% |
| 2011 Q3 | 31.13 Million INR | 22.46% |
| 2010 FY | 70.12 Million INR | 56.46% |
| 2009 FY | 44.82 Million INR | 47.68% |
| 2008 FY | 30.34 Million INR | 163.94% |
| 2007 FY | 11.49 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -255136.457% |
| Aarti Drugs Limited | 7.14 Billion INR | -1.071% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -130.979% |
| Ajanta Pharma Limited | 19.67 Billion INR | 63.281% |
| Alembic Limited | 767.77 Million INR | -841.076% |
| Alkem Laboratories Limited | 19.46 Billion INR | 62.875% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -25.481% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -61.499% |
| Bal Pharma Limited | 214.56 Million INR | -3267.355% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -34879.183% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -486.945% |
| Brooks Laboratories Limited | -72.25 Million INR | 10100.138% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2940.171% |
| Divi's Laboratories Limited | 18.31 Billion INR | 60.539% |
| Eris Lifesciences Limited | 5.18 Billion INR | -39.438% |
| Granules India Limited | 6.52 Billion INR | -10.677% |
| Ind-Swift Limited | 1.22 Billion INR | -489.357% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -3275.677% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 4.195% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -39.243% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3372.867% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 277.11 Million INR | -2507.301% |
| Wockhardt Limited | 140 Million INR | -5060.929% |
| Orchid Pharma Limited | 2.36 Billion INR | -206.017% |
| RPG Life Sciences Limited | 2.29 Billion INR | -215.199% |
| Shilpa Medicare Limited | 3.76 Billion INR | -92.082% |
| Sigachi Industries Limited | 1.47 Billion INR | -390.218% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 287.529% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -114696.632% |
| Wanbury Limited | 1.7 Billion INR | -323.223% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 84.082% |
| FDC Limited | 3.03 Billion INR | -138.165% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -1063.444% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 89.332% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 19.533% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -259.641% |
| Laurus Labs Limited | 3.94 Billion INR | -82.984% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -26214.007% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -85.712% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1209.907% |
| Hester Biosciences Limited | 364.77 Million INR | -1880.782% |
| Ipca Laboratories Limited | 29.59 Billion INR | 75.587% |
| Venus Remedies Limited | 534.65 Million INR | -1251.405% |
| ZIM Laboratories Limited | 1.09 Billion INR | -557.974% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 93.086% |
| Morepen Laboratories Limited | 4.17 Billion INR | -73.11% |
| Neuland Laboratories Limited | 5.31 Billion INR | -35.863% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -56.811% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Windlas Biotech Limited | 1.29 Billion INR | -456.267% |
| Hikal Limited | 1.49 Billion INR | -383.556% |
| Innova Captab Limited | 2.53 Billion INR | -185.201% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -159.343% |
| Themis Medicare Limited | 1.3 Billion INR | -454.468% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -46.196% |
| Mankind Pharma Limited | 40.86 Billion INR | 82.32% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -11.118% |
| Sakar Healthcare Limited | 495.5 Million INR | -1358.166% |
| Albert David Limited | 1.33 Billion INR | -441.441% |
| Lupin Limited | 27.75 Billion INR | 73.97% |
| Gufic Biosciences Limited | 2.89 Billion INR | -149.682% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 93.073% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -279.017% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2798.805% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 71.481% |
| NATCO Pharma Limited | 25.96 Billion INR | 72.17% |
| Suven Life Sciences Limited | -1.22 Billion INR | 689.425% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -38.262% |
| Indoco Remedies Limited | 1.52 Billion INR | -373.977% |
| Alpa Laboratories Limited | 61.51 Million INR | -11645.591% |
| Lasa Supergenerics Limited | -458 Million INR | 1677.559% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 275.583% |